Investing.com -- Piper Sandler raised its price target on Teva Pharmaceutical Industries to $40 from $30, arguing the ...

The year 2025 has witnessed a remarkable rise of trailblazers across business, social impact, wellness, and creative domains.

Over the past two decades, I’ve observed significant shifts in the life sciences, pharmaceutical, and CDMO landscape. Pharmaceutical companies and their outsourcing partners must continuously adapt to ...

Amgen Inc. raises 2025 revenue guidance on strong Repatha and Imdelltra sales and dividend hike. Click for this AMGN update.

Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company ...

Do you want to be on the forefront of modern pharmaceuticals? The demand for pharmaceutical chemists is high and is anticipated to grow as modern chemistry and biology provide us with increasingly ...

About Xeris Biopharma Holdings Inc. Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has ...